GlassScriptPhysician profile
Denise Albury
NPI 1417053257
$1,856.65
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $290 · 2021: $385 · 2022: $269 · 2023: $243 · 2024: $224 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $389.10 | 2019-2025 | |
| Glaxosmithkline, LLC. | $383.87 | 2019-2025 | Rotarix, Bexsero, Penmenvy |
| Sanofi Pasteur INC. | $330.83 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $297.13 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $198.59 | 2019-2025 | Doc Band |
| Phadia US INC. | $119.04 | 2020-2024 | Immunocap |
| Sobi, INC | $45.66 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $22.87 | 2025 | |
| Seqirus USA INC | $22.52 | 2025 | Flucelvax |
| Sarepta Therapeutics, INC. | $18.63 | 2020 | |
| Cognoa, INC. | $14.73 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.68 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Albury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.